← Browse by Condition
Medical Condition

healthy control

Total Trials
2
Recruiting Now
2
Trial Phases
Various

Clinical trials often recruit healthy volunteers for Phase 1 pharmacokinetic and safety studies, vaccine immunogenicity assessments, and normal physiological reference studies. These trials are essential for establishing safe dose ranges and understanding how drugs behave in the absence of disease before testing in patient populations.

Healthy volunteer studies include first-in-human drug trials, vaccine efficacy (flu, RSV, COVID-19, malaria), microbiome intervention studies, exercise physiology research, and device safety assessments. Compensation is often provided; eligibility typically requires no significant medical history and a negative drug screen.

Healthy volunteer trials require participants to be in good general health with no significant medications. Many exclude smokers, pregnant individuals, and those with recent prior trial participation.

Frequently Asked Questions — healthy control Clinical Trials

How many clinical trials are currently recruiting for healthy control?
ClinicalMetric currently tracks 2 actively recruiting clinical trials for healthy control, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 2. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for healthy control?
healthy control research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a healthy control clinical trial?
Eligibility criteria for healthy control trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Beijing Tiantan Hospital 1 trial
KU Leuven 1 trial

Recruiting Clinical Trials

NCT07392411
Recruiting
Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Biomarkers
Enrollment
720 pts
Location
China
Sponsor
Beijing Tiantan Hospital
View Trial →
NCT07328178
Recruiting
Analysis of the Role of IgE Proteoforms in Health and Disease
Enrollment
200 pts
Location
Belgium
Sponsor
KU Leuven
View Trial →

Related Conditions

parkinson s disease (1) progressive supranuclear palsy psp (1) multiple system atrophy (1) anaphylaxis (1) mastocytosis (1) x linked agammaglobulinaemia (1) venom allergy (1) chronic spontaneous urticaria csu (1) type i allergy (1) medication allergy (1) hereditary alpha tryptasemia (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology